• PCR256 Humanistic Burden and Prevalence of Mental Conditions Among COVID-19 Patients in Japan and China

    Dec 1, 2022, 00:00

  • HTA202 Learnings From First TC Opinions of Drugs Evaluated for EAP Under New Process

    Dec 1, 2022, 00:00

  • Advances in Cost-Effectiveness Analysis Methods

    Dec 1, 2022, 00:00

  • CO170 Efficacy and Safety of Golimumab in Pediatric Ulcerative Colitis: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • CO164 Real-World Outcomes and Treatments Patterns of Metastatic Castration-Resistant Prostate Cancer Patients: An Italian Retrospective Study

    Dec 1, 2022, 00:00

  • RWD141 Exploration of Melanoma Patient-Generated Real-World Data Using an Ai-Based Social Listening Approach

    Dec 1, 2022, 00:00

  • RWD51 Demonstrating Internal and External Validity in Real-World Datasets: A Case Study in MET Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2022, 00:00

  • EE406 Colorectal Cancer Screening - Benefit-Harm and Cost-Effectiveness Analysis of Population-Wide Screening Strategies in Austria

    Dec 1, 2022, 00:00

  • EE229 Cost-Effectiveness Analysis of Eremumab (Aimovig®) for the Preventive Treatment of Migraine in Spain

    Dec 1, 2022, 00:00

  • HTA106 HTA and Reimbursement Timelines in the Republic of Ireland

    Dec 1, 2022, 00:00

  • CO27 Evaluation of Antiseptics and the Microbiological Environment Regarding Complications of Phlebitis Caused by Peripheral Cannulas

    Dec 1, 2022, 00:00

  • HTA27 Implications of an EU-Wide Joint Clinical Assessment on the Scope of the Decision Problem

    Dec 1, 2022, 00:00

  • HTA237 Cost-Effectiveness Analysis of Ofatumumab for Relapsing Remitting Multiple Sclerosis Treatment in Italy

    Dec 1, 2022, 00:00

  • CO80 Surrogate Endpoints for Overall Survival in Cutaneous Squamous Cell Carcinoma: A Meta-Regression of Clinical Trials

    Dec 1, 2022, 00:00

  • HPR90 A Quasi-Experimental Study of the Effects of the Affordable Care Act (ACA) Marketplaces Subsidies on Access to Care and Healthcare Utilization of Nonelderly Adults With Chronic Conditions

    Dec 1, 2022, 00:00

  • SA25 Evolution of the Number of Metastatic Lung Cancer Patients before and during the COVID 19 Pandemic: A French National Hospital Database Analysis

    Dec 1, 2022, 00:00

  • PCR100 Reading and Labeling Medical Discharge Summaries Using Artificial Intelligence to Improve Medical Discharge Process

    Dec 1, 2022, 00:00

  • PCR190 Health-Related Quality of Life Outcomes of Very Preterm or Very Low Birth Weight Adults: Evidence From an Individual Participant Data Meta-Analysis

    Dec 1, 2022, 00:00

  • EPH22 A Systematic Literature Review of the Epidemiology Associated With Human Monkeypox in Children and Adults in India

    Dec 1, 2022, 00:00

  • PCR59 A Systematic Literature Review of Humanistic Burden in Huntington's Disease

    Dec 1, 2022, 00:00

  • Disparities in Access to Radiation Therapy by Race and Ethnicity in the United States With Focus on American Indian/Alaska Native People

    Dec 1, 2022, 00:00

  • EPH41 Evaluating Population Health Priorities for Community Health Workers

    Dec 1, 2022, 00:00

  • PCR232 The Use of EuroQol EQ-5D in the Middle East and North Africa Region: A Systematic Review

    Dec 1, 2022, 00:00

  • HPR70 Developing the Risk-Adjusted Capitation Payment for Patients With Diabetes Mellitus in China: Results From Administrative Data in Tianjin

    Dec 1, 2022, 00:00

  • HTA128 Reassessment of Orphan Drugs After Exceeding the 50 Mio. Euro Revenue Threshold: Effects on Added Benefit and Price Discount

    Dec 1, 2022, 00:00

  • PCR105 Examination of Surgical Indications and Previous Hip Replacement Surgery Among Hip Prosthesis Patients in State and Private Health Care

    Dec 1, 2022, 00:00

  • PCR54 Patient Preferences With Rheumatological or Dermatological Diseases Regarding Electronic Injection Devices for the Administration of Etanercept in Colombia

    Dec 1, 2022, 00:00

  • PCR155 A Theoretical Model on Pediatric Nurses’ Burnout, Wellbeing, and Patient Safety

    Dec 1, 2022, 00:00

  • EE321 Use of Single-Arm Trials in NICE Reviews of Oncology Drugs

    Dec 1, 2022, 00:00

  • CO87 Reductions in Exacerbations and Improvements in Lung Function and Asthma Control in Children With Moderate-to-Severe Type 2 Asthma Analyzed by High- or Medium-Dose of Inhaled Corticosteroids at Baseline

    Dec 1, 2022, 00:00

  • Public Health

    Dec 1, 2022, 00:00

  • EE137 Evaluating the Effects of the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model Risk Factor Progression Equations on Cost-Utility Outcomes in Type 2 Diabetes: Analyses Using the Prime Diabetes Model

    Dec 1, 2022, 00:00

  • P43 Navigating the Maze of Standard and Novel Population-Adjusted Indirect Comparison (PAIC) Methods

    Dec 1, 2022, 00:00

  • EPH177 Assessing Student Pharmacists’ Knowledge and Perceptions of Electronic Nicotine Delivery Systems (ENDS) – A Cross Sectional Study at One College of Pharmacy

    Dec 1, 2022, 00:00

  • EE174 Public Health Impact of Switching From a Trivalent to a Quadrivalent Inactivated Influenza Vaccine in Ecuador

    Dec 1, 2022, 00:00

  • PCR211 VOCAL (Views of Ovarian Cancer Patients and Their Caregivers-How Maintenance Therapy Affects Their Lives) Study: Cancer-Related Burden and Quality of Life of Caregivers

    Dec 1, 2022, 00:00

  • SA73 Addressing Unmet Needs of Patients With Neuronopathic Gaucher Disease Type 2 and Type 3: Creation of the GARDIAN Patient Registry

    Dec 1, 2022, 00:00

  • EE407 Budget Impact Analysis of the Use of Emicizumab in Prophylaxis for Severe Hemophilia A and Inhibitors in the Pediatric Population of the Dominican Republic

    Dec 1, 2022, 00:00

  • CO110 Systematic Literature Review (SLR) and Meta-Analysis (MA) of Clinical Outcomes for Second-Line and Higher (≥2L) Targeted Therapies for Advanced Colorectal Cancer (aCRC)

    Dec 1, 2022, 00:00

  • CO55 Radiographic Progression-Free Survival (RPFS) as a Surrogate Endpoint for Overall Survival (OS) in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (MCRPC): A Correlation Meta-Analysis

    Dec 1, 2022, 00:00

  • Real-World Evidence to Inform Healthcare Decision Making

    Dec 1, 2022, 00:00

  • CO12 Prevalence and Factors Associated With Hypoparathyroidism After Total Thyroidectomy for Thyroid Cancer: A French Nationwide Claims Database Study

    Dec 1, 2022, 00:00

  • MSR55 Extraction of Ejection Fraction From Clinical Notes Using a Pretrained Albert-for-Question-Answering Model

    Dec 1, 2022, 00:00

  • EE337 An Economic Assessment of Incorporating an Acellular Hexavalent Vaccine as Part of the National Immunization Program of Peru

    Dec 1, 2022, 00:00

  • PCR134 Uncertainties in Evaluating Patient and Caregiver Health-Related Quality of Life and Disease Burden in NICE HST Submissions

    Dec 1, 2022, 00:00

  • RWD81 Analysis of Clinical Outcomes, Health Resource Use and Costs of Patients With Non-Valvular Atrial Fibrillation Treated With Apixaban vs Acenocoumarol in Routine Clinical Practice in Spain

    Dec 1, 2022, 00:00

  • RWD59 Disparity in Breast Cancer Female Undergoing Reconstructive Procedures: A Real-World Analysis

    Dec 1, 2022, 00:00

  • HTA222 How to Increase the Public Legitimacy of Healthcare Resource Allocation Processes: Lessons From an Israeli Case Study

    Dec 1, 2022, 00:00

  • MSR11 Evaluating the Impact of Exact Logistic Regression on Matching Adjusted Indirect Comparisons (MAICs) of Treatments Between Trials: A Simulation Study

    Dec 1, 2022, 00:00

  • EE99 Cost-Effectiveness of Percutaneous Closure of a Patent Foramen Ovale (PFO) Versus Antiplatelet Therapy After Stroke: A Trial and Model Based Economic Evaluation of the French Close Randomised Controlled Trial

    Dec 1, 2022, 00:00

  • EE5 Cost-Utility Analysis of Aripiprazole, Olanzapine Branded Generic, and Olanzapine Generic on Stable Phase of Schizophrenia Patient at Mental Health Hospital in Jakarta

    Dec 1, 2022, 00:00

  • PCR290 Patient Preferences and Cost-Benefit of Hypertension and Hyperlipidemia Collaborative Management Model Between Pharmacies and Primary Care in Portugal: A Discrete Choice Experiment Alongside a Trial (USFARMÁCIA®)

    Dec 1, 2022, 00:00

  • EE221 Healthcare Resource Utilization and Costs of Myotubular Myopathy in England

    Dec 1, 2022, 00:00

  • MSR51 Predictors of Hospitalization in Patients With Newly Diagnosed Major Depressive Disorder: A Real-World Evidence Study

    Dec 1, 2022, 00:00

  • HSD17 Treatment Pattern of the Opioid Injection Prescriptions in South Korea

    Dec 1, 2022, 00:00

  • SA32 Adapting PROs Evaluation to COVID Context – The Case of ASCEND Study

    Dec 1, 2022, 00:00

  • Innovative Methods in Indirect Treatment Comparisons

    Dec 1, 2022, 00:00

  • EE460 A Systematic Review of the Methodological Aspects of Applied Economic Evaluations in the Palliative and End-of-Life Care Settings

    Dec 1, 2022, 00:00

  • EE265 Health, Productivity and Budget Impact of Vaccinating 50-64 Year Old Employees in Austria Against Herpes Zoster With Recombinant Zoster Vaccine

    Dec 1, 2022, 00:00

  • CO89 Integrated Analysis of Efficacy and ICU Length of Stay Data From Phase 2 and Phase 3 Trials of Rezafungin for the Treatment of Invasive Candidiasis and/or Candidemia

    Dec 1, 2022, 00:00

  • PCR118 Valuation of the EQ Health and Well-being Short Using Time Trade-Off and Discrete Choice Experiments: A Feasibility Study

    Dec 1, 2022, 00:00

  • MSR130 Comparison of Software for Bayesian Network Meta-Analysis: A Case Study of Binomial Outcomes in Ulcerative Colitis

    Dec 1, 2022, 00:00

  • EE507 Insulin Degludec/Insulin Aspart Versus Basal+Bolus Insulin Treatment (Insulin Glargine U100 Insulin Aspart) in T2D in India: A Short-Term Cost-Effectiveness Analysis Based on the Step-By-Step Clinical Trial

    Dec 1, 2022, 00:00

  • HTA259 Overlaps and Differences in the PICO Criteria Between the Different EU Countries

    Dec 1, 2022, 00:00

  • EPH143 Hepatic Disorders of Pirfenidone or Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF): A Systematic Review

    Dec 1, 2022, 00:00

  • EE4 Hospital Care of Endometriosis in Spain: A Retrospective Multicenter Analysis of Patient Characteristics and Costs

    Dec 1, 2022, 00:00

  • EE405 A UK Cost-Minimisation Analysis of Brolucizumab Versus Aflibercept in Diabetic Macular Oedema (DMO)

    Dec 1, 2022, 00:00

  • MT6 Real World Clinical Data on the Use of a Natural Molecular Complex for the Treatment of Irritable Bowel Syndrome in Specialist Daily Practice

    Dec 1, 2022, 00:00

  • HPR10 Building Bridges Between Regulation, Health Technology Assessment and Clinical Guideline Development

    Dec 1, 2022, 00:00

  • EPH200 Prevalence and Treatment Patterns of Generalized Pustular Psoriasis (GPP) in Germany – Results of a Delphi Consensus Study

    Dec 1, 2022, 00:00

  • MSR19 An Update on Real-Time Application of Machine Learning Programs to Improve Cardiovascular Risk Prediction in European Population

    Dec 1, 2022, 00:00

  • EPH201 Systematic Review of the Accuracy of T-Cell Receptor Excision Circle (TREC)-Based Newborn Screening for Severe Combined Immunodeficiency (SCID)

    Dec 1, 2022, 00:00

  • EE130 Cost-Utility of Cabonivo vs Sunitinib, Pazopanib and Ipinivo for First Line Advanced Renal-Cell Carcinoma in the Private Healthcare System in Brazil

    Dec 1, 2022, 00:00

  • EE334 Cost-Effectiveness Analysis of Nivolumab as an Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma at High Risk of Recurrence in Greece

    Dec 1, 2022, 00:00

  • HSD106 Analysis of Diagnostic and Medical Delay Data Among Lung Cancer Patients in 2019 and 2020

    Dec 1, 2022, 00:00

  • PCR42 Examination of Quality of Life and Sexual Functions Among Women With Cervical Cancer

    Dec 1, 2022, 00:00

  • HTA199 The Reality of Living Systematic Literature Reviews to Support Timely Healthcare Decisions: A Case Study in Relapsed/Refractory Multiple Myeloma

    Dec 1, 2022, 00:00

  • HPR31 Analysis of the Difference Between Tender and Reimbursement Prices of Cardiovascular Surgery Medical Devices in Turkiye Between 2017-2021

    Dec 1, 2022, 00:00

  • EE179 Cost-Effectiveness of Robot-Assisted Total Hysterectomy for Benign Pathologies Compared to Laparoscopic and Open Surgery: A Retrospective Study

    Dec 1, 2022, 00:00

  • SA50 Claims-Based Estimates of Bleeding Rates in Hemophilia B Patients on Factor IX Therapy in the United States

    Dec 1, 2022, 00:00

  • HPR15 Out-of-Pocket Pharmaceutical Payments and Their Poverty Impact on Patients in Greece

    Dec 1, 2022, 00:00

  • EPH37 High Cardiovascular Disease Risk and Low Lipid-Lowering Treatment in Heterozygous Familial Hypercholesterolemia Patients: A French Nationwide Registry

    Dec 1, 2022, 00:00

  • EPH101 Application Processes for International Classification of Disease (ICD)-11 Update and Revision Proposals

    Dec 1, 2022, 00:00

  • MSR126 Economic and Humanistic Burden in Patients With Obstructive Hypertrophic Cardiomyopathy - A Systematic Literature Review

    Dec 1, 2022, 00:00

  • PCR41 Is Enhancing Health-Related Quality of Life Correlated to Direct-Acting Antivirals Adherence in Chronic Hepatitis C Virus Patients? A Romanian Prospective Cohort Study

    Dec 1, 2022, 00:00

  • HPR14 Identifying the Key Drivers of Biosimilar Uptake in Paris University Hospitals Using a Principal Component Analysis

    Dec 1, 2022, 00:00

  • EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19

    Dec 1, 2022, 00:00

  • EPH69 Health Inequity in Viral Infections in a Medicaid Population: Lessons From Influenza and COVID-19

    Dec 1, 2022, 00:00

  • HTA31 Understanding Pricing and Reimbursement Conditions to Facilitate PR Negotiations in Spain: A 5-Year Review (2017-2022)

    Dec 1, 2022, 00:00

  • EE424 Picking Petals Off the Value Flower – The Need to Consider Insurance Value for New Medical Technologies

    Dec 1, 2022, 00:00

  • HSD31 Analysis of the Balanced Scorecard's Managerial Subdimensions in Health Care Organizations During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • HPR127 Managing Uncertainty for the Orphans: A Belgian Perspective on Managed Entry Agreements for Orphan Drugs

    Dec 1, 2022, 00:00

  • RWD99 The Financial Burden of DM on the Public Health System of Gree Using Big Data From Greece

    Dec 1, 2022, 00:00

  • MT9 Cost-Utility of Bone Conduction Implants for Conductive or Mixed Hearing Loss or Single-Sided Deafness: A Decision Analysis

    Dec 1, 2022, 00:00

  • EE589 Cost-Effectiveness of Once-Daily Somatropin From Sandoz Versus Once-Weekly Somatrogon for the Treatment of Growth Hormone Deficiency in Children and Adolescents

    Dec 1, 2022, 00:00

  • SA69 Differences in Evidence Requirements of HTA Authorities in UK, Italy, Netherlands, Poland, Portugal, and Sweden to Appraise New Products

    Dec 1, 2022, 00:00

  • EE627 Inclusion of Environmental Sustainability in the Economic Analysis of Healthcare Interventions: A Review of Policy Approaches

    Dec 1, 2022, 00:00

  • EPH210 Impact of Distance Learning on Development of Emotional Intelligence of Medical Bachelor Students

    Dec 1, 2022, 00:00

  • EE346 Comparison of Diagnosis, Administration, and Treatment-Related Cost of Targeted Radiopharmaceutical Therapies in Patients With Metastatic Castration-Resistant Prostate Cancer (MCRPC) From a Third-Party Payer Perspective

    Dec 1, 2022, 00:00

  • EE400 Comparing the Budget Impact of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres Versus Drug Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma in England

    Dec 1, 2022, 00:00

  • EE243 Cost-Effectiveness Model Conceptualisation in Fibrodysplasia Ossificans Progressiva

    Dec 1, 2022, 00:00

  • PCR152 Underutilization of a Validated Treatment Satisfaction Instrument in Inflammatory Bowel Disease

    Dec 1, 2022, 00:00

  • MSR110 A Comparison of Stan Versus WinBUGS Software for Conducting Bayesian Hazard Ratio-Based Network Meta-Analysis

    Dec 1, 2022, 00:00

  • RWD117 Body Surface Area of Adult Cancer Patients: An Italian Multicenter Retrospective Study

    Dec 1, 2022, 00:00

  • EE496 Triple Negative Breast Cancer-Related Mortality in Central and Eastern Europe: Years of Life Lost and Productivity Costs

    Dec 1, 2022, 00:00

  • PCR75 Comparing Choice Share Prediction Methods for Discrete Choice Experiments: A Case Study With Hypomethylating Agents in Myelodysplastic Syndromes

    Dec 1, 2022, 00:00

  • RWD65 Burden of Developmental Disabilities and Ethnic Differences in Utilization of Non-Pharmacotherapies Among Children in the US

    Dec 1, 2022, 00:00

  • EPH191 The Epidemiology of Male Breast Cancer in Eight High-Income European Countries

    Dec 1, 2022, 00:00

  • RWD33 Analysis of COVID-19 Vaccine-Related Adverse Events in Adults, Geriatrics and Pediatrics – A Retrospective Study

    Dec 1, 2022, 00:00

  • RWD105 Clinical Differences and Patient Reported Outcomes Between Insufficient Responders and Responders to Prescribed Acute Migraine Treatment: Results From a Real-World Patient Survey in China

    Dec 1, 2022, 00:00

  • RWD45 Real-World Data to Support Surrogate Endpoint Evaluation for Health Technology Assessment

    Dec 1, 2022, 00:00

  • RWD145 The Direct Cost Savings and Indirect Value of Using Artificial Intelligence With Clinical Disease Specific Quality Register Data - Case Helsinki University Eye Clinic: Cataract Register and Retina Register

    Dec 1, 2022, 00:00

  • HTA24 Real-World Data as External Controls for Single-Arm Trials: Role in Regulatory and Health Technology Assessments

    Dec 1, 2022, 00:00

  • RWD75 Healthcare Cost for Patients With Chronic Rhinosinusitis With Nasal Polyps and Comorbid Asthma

    Dec 1, 2022, 00:00

  • MSR132 Integrating Relative Survival Framework for Survival Extrapolation in Multi-State Models—An Application to Predicting Quality-Adjusted Life Years for Chronic Myeloid Leukemia Patients

    Dec 1, 2022, 00:00

  • HPR25 Patient Organisations' Submissions to the Pharmaceutical Pricing Board in Finland

    Dec 1, 2022, 00:00

  • CO88 The Impact of COVID-19 Pandemic on Health-Related Quality of Life Outcomes: Evidence From a Longitudinal Study on Children With Rare Disorders

    Dec 1, 2022, 00:00

  • EE91 Economic Evaluation of Durvalumab for the Treatment of Patients With Stage III Unresectable Locally Advanced Non-Small Cell Lung Cancer Whose Disease Has Not Progressed After Platinum-Based Chemoradiation Therapy

    Dec 1, 2022, 00:00

  • EPH27 Examining the Risk Behaviour of Young People

    Dec 1, 2022, 00:00

  • RWD64 Identifying Patient-Level Social Determinants of Health in Unstructured Clinical Notes From Electronic Health Records

    Dec 1, 2022, 00:00

  • EPH58 A Theoretical Estimation of the Future Prevalence of Osteoporosis in Patients Undergoing Spine Fusion Surgery in Japan by 2050

    Dec 1, 2022, 00:00

  • HTA123 An Exploration of Patient Involvement in NICE and SMC Appraisals of Breast and Ovarian Cancer Therapies

    Dec 1, 2022, 00:00

  • PCR50 Measuring Health From a Broad Perspective: Preferences Assessed Among Various Professional Stakeholder Groups

    Dec 1, 2022, 00:00

  • RWD104 Delayed Diagnosis Amongst gMG Patients: Results From a European Real-World Study

    Dec 1, 2022, 00:00

  • EE315 Cost-Effectiveness Analysis of Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes in China

    Dec 1, 2022, 00:00

  • CO72 Predicting Sojourn Times by Dementia Stages: Evidence From 76,747 Patients in the Swedish National Registry for Cognitive Disorders (SVEDEM)

    Dec 1, 2022, 00:00

  • EE257 Cost-Effectiveness Analysis of AI-Assisted Radiological Assessment in Patients With Relapsing Remitting Multiple Sclerosis in the UK

    Dec 1, 2022, 00:00

  • HSD53 Analysis of the Balanced Scorecard's Internal Subdimensions in Health Care Organizations During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • EPH84 Prevalence of Polysubstance Use of Opioids in Pregnant Women and Medication-Assisted Treatment: Evidence from the United States Treatment Episode Data Set

    Dec 1, 2022, 00:00

  • EE76 Budget Impact of Subcutaneous Infliximab in Comparison to Intravenous Infliximab in the Management of Autoimmune Diseases in Greece

    Dec 1, 2022, 00:00

  • CO175 Systematic Literature Review of Outcomes in Patients With Advanced Basal Cell Carcinoma (ABCC) Who Progressed on or Are Intolerant to Hedgehog Inhibitors (HHI)

    Dec 1, 2022, 00:00

  • EPH166 Idiopathic Pulmonary Fibrosis (IPF : Epidemiology and Characteristics of Patients in Morocco

    Dec 1, 2022, 00:00

  • HSD14 Lacking Observance of the Guidelines on Dyslipidaemias as Possible Reason for Low LDL-C Goal Attainment in Patients at High and Very High Cardiovascular Risk

    Dec 1, 2022, 00:00

  • HTA78 Evaluations of Cost-Utility Analyses of Pharmaceuticals Receiving Market Authorization Based on Single-Arm Trials in the Netherlands

    Dec 1, 2022, 00:00

  • EE580 Costs of Chronic Kidney Failure and Diabetic Nephropathy in Turkiye

    Dec 1, 2022, 00:00

  • CO134 Systematic Review of the Impact of Early Versus Late Diagnosis and/or Hematopoietic Stem Cell Transplantation (HSCT) for Severe Combined Immunodeficiency (SCID)

    Dec 1, 2022, 00:00

  • EPH66 Underground Economy - A Parameter of Social Influence During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • HTA260 Informal Carer Disutility: How Many Caregivers Are Captured in Cost-Utility Analyses of Treatments for Rare Diseases Submitted for NICE Highly Specialised Technology Appraisals?

    Dec 1, 2022, 00:00

  • HTA124 Real-World Data to Inform Health Technology Assessments in England: A Review of Submissions to the National Institute for Health and Care Excellence Since 2018

    Dec 1, 2022, 00:00

  • EE236 Hospital Incidence and Medical Costs of Polycythemia Vera in Spain: A Retrospective Database Analysis

    Dec 1, 2022, 00:00

  • EE308 Budget Impact Analysis (BIA) of Medical Activity on Fractional Flow Reserve Measurement (FFR) for Functional Assessment of Epicardial Stenoses in Patients With Stable Coronary Heart Disease

    Dec 1, 2022, 00:00

  • EPH119 The Economic Burden of Illness (BOI) of the Globally Spreading Chikungunya Virus (CHIKV): A Systematic and Targeted Literature Review (SLR AND TLR)

    Dec 1, 2022, 00:00

  • HPR19 Tax Revenue Gains and Societal Net-Monetary Benefit Associated With Implementing Lung Cancer Screening in the United Kingdom

    Dec 1, 2022, 00:00

  • CO17 Real-World Data (RWD) Collection Alongside Early Access to Medicines Scheme (EAMS) - Nivolumab in Advance Squamous Cell Oesophageal Cancer After Prior Chemotherapy

    Dec 1, 2022, 00:00

  • HSD1 Treatment With Dual and Triple Therapy in Chronic Obstructive Pulmonary Disease in Line With Current Guidelines Reduces the Carbon Footprint

    Dec 1, 2022, 00:00

  • MSR105 Artificial Intelligence/Machine Learning (AI/ML) Techniques for Risk/Outcomes Prediction in Patients With Myocardial Infarction (MI) – A Targeted Literature Review (TLR)

    Dec 1, 2022, 00:00

  • EE621 Cost of Illness of Vaccine-Preventable Diseases in France

    Dec 1, 2022, 00:00

  • PCR28 Utility Values Derived From Canadian Adults With Toenail Onychomycosis With and Without Comorbid Diabetes Mellitus: A Study Using the Health Utilities Index®

    Dec 1, 2022, 00:00

  • EE193 Lorlatinib as a First-Line Treatment for ALK+ Advanced Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis in Spain

    Dec 1, 2022, 00:00

  • P59 Automated Literature Screening Using Artificial Intelligen A Meta-Analysis of Different Algorithm Results

    Dec 1, 2022, 00:00

  • HTA99 NICE Evaluations of Oncology Products With EMA Conditional Marketing Authorisation

    Dec 1, 2022, 00:00

  • RWD25 The Phollow Cohort: Real-World Therapeutic Adherence to Blood Glucose Lowering Drugs (Excluding Insulins) in Portugal

    Dec 1, 2022, 00:00

  • HTA72 Examining the Effectiveness of the Cancer Drugs Fund: Are Data Collection Plans Working as Intended?

    Dec 1, 2022, 00:00

  • EPH64 Public Health Impact of COVID-19 in French Ambulatory Patients With at Least One Risk Factor for Severe Disease

    Dec 1, 2022, 00:00

  • P26 Disinvestment Impact, Processes, Policies and Experiences Worldwide: A Systematic Review

    Dec 1, 2022, 00:00

  • CO57 Modeling Adherence to Positive Airway Pressure Therapy in Women With Obstructive Sleep Apnea

    Dec 1, 2022, 00:00

  • PCR140 Higher Need for Medical and Societal Resources of Moderately-to-Severely Affected Myasthenia Gravis Patients in Comparison to the General Population: Analysis of Digitally Collected Observational Data From 8 Countries

    Dec 1, 2022, 00:00

  • RWD159 Use of RWD to Support Healthcare Decision Making in Japan: The Devil Lies in the 'D' - How Is the Data Landscape Evolving in Japan?

    Dec 1, 2022, 00:00

  • EE335 Cost-Efectiveness Analysis Between Multichambered Standarized Pediatric Parental Nutrition and Individualized Compounded Parental Nutrition, Analysis From the Mexican Public Health System Perspective

    Dec 1, 2022, 00:00

  • EE143 Cost-Effectiveness of Ofatumumab Compared with Other Disease-Modifying Therapies for the Treatment of Relapsing Multiple Sclerosis in Greece

    Dec 1, 2022, 00:00

  • EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine as a Potential Booster Vaccine Option for Adults in the United States

    Dec 1, 2022, 00:00

  • MSR143 How Uncertain Is Uncertainty Testing in Budget Impact Models?

    Dec 1, 2022, 00:00

  • HTA16 Purchasing Implantable Medical Devices in Egypt Using a Multicriteria Decision Analysis (MCDA) Tool

    Dec 1, 2022, 00:00

  • EE66 Tiered Pricing and Other Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature

    Dec 1, 2022, 00:00

  • EPH73 Diet Quality During the First Two Years of Life and the Women, Infants and Children Program

    Dec 1, 2022, 00:00

  • EPH193 Assessment of Diuretic Drug Consumption in Ukraine

    Dec 1, 2022, 00:00

  • EE133 Budget Impact Related to Complications on Post-Bariatric Surgery Patients in Brazilian Public Healthcare System

    Dec 1, 2022, 00:00

  • HPR80 Assessing Performance of TB Management Through NTEP By 2025: An Initiative From the Indian Government a Roadmap Ahead of Sustainable Goal in India 2030

    Dec 1, 2022, 00:00

  • HSD11 Evaluation of the Implementation Progress of a New Complex Intervention in a Multimorbidity Patient-Centered Care Model in Chile

    Dec 1, 2022, 00:00

  • RWD114 Investigating the Impacts of Comorbid Conditions on Costs and Length of Stay in Secondary Care Among Adults Infected With Influenza in England

    Dec 1, 2022, 00:00

  • MSR31 Evidence Synthesis for Decision-Making: Is Meta-Analysis Always Required?

    Dec 1, 2022, 00:00

  • MSR127 Generalizability of Trial-Based Economic Evaluations. Methods to Account for Covariates and Impact on Cost-Effectiveness and Value of Information

    Dec 1, 2022, 00:00

  • PCR188 Unearthing Social Determinants of Health From a Patient-Focused Web Platform

    Dec 1, 2022, 00:00

  • PCR15 Throat Pain and Discomfort Associated With Transesophageal Echocardiography in Chinese Atrial Fibrillation Patients With Planned Radio-Frequency Ablation: A Patient Survey Study

    Dec 1, 2022, 00:00

  • PCR237 Effect of Eptinezumab on Utility Scores in Patients With Migraine: Results From the Deliver Study

    Dec 1, 2022, 00:00

  • CO97 Assessment of Enhanced Efficacy of Multiple CYTOPOINT Injections

    Dec 1, 2022, 00:00

  • RWD85 Trends in Medicine Utilization and Its Expenditure for Treating Lung Cancer in Catalonia

    Dec 1, 2022, 00:00

  • EPH124 Prediction Model to Evaluate the Impact of a Next Generation Bivalent Omicron-Containing COVID-19 Booster (MRNA.1273.214) on Hospitalizations in Adults in Germany

    Dec 1, 2022, 00:00

  • CO81 A Bayesian Approach to Increase Evidence of Effectiveness in Health Economic Evaluations of Treatments for Rare Diseases

    Dec 1, 2022, 00:00

  • MSR76 Evaluation of the Use of Topic Modelling (TM) to Support Systematic Literature Review (SLR) Updates for Screening Truncation of Non-Relevant Citations

    Dec 1, 2022, 00:00

  • EE399 Exploring the Effect of Different Patient Entry Intervals on Budget Impact Estimations

    Dec 1, 2022, 00:00

  • CO18 Exploring Endpoint Correlation Between Progression Free Survival (PFS) and Overall Survival (OS) in Previously Untreated Metastatic Melanoma Using Pseudo Individual Patient Data (IPD)

    Dec 1, 2022, 00:00

  • PCR31 Patient and Caregiver Preferences for the Treatment of Duchenne Muscular Dystrophy: A Quantitative Patient Preference Study

    Dec 1, 2022, 00:00

  • EE23 Costs, Consequences and Budget Impact of Implementing a 2-Dose or 3-Dose Rotavirus Vaccine in the United Kingdom

    Dec 1, 2022, 00:00

  • HPR173 Criteria to Define Rare Diseases and Orphan Drugs: Systematic Literature Review

    Dec 1, 2022, 00:00

  • EE151 Health Utilities Associated With Sacituzumab Govitecan (SG) for Treating Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer (MTNBC)

    Dec 1, 2022, 00:00

  • EE102 Economic and Organisational Impact of an Innovative Treatment With Extended Durability for Retinal Diseases Reducing the Annual Frequency of Intravitreal Injections in France

    Dec 1, 2022, 00:00

  • EPH88 Determinants of Caregiving Burden Among Caregivers of Adult Patients With Beta-Thalassemia Major in China

    Dec 1, 2022, 00:00

  • The Role of Real-World Data in HTA and Regulatory Decision-Making

    Dec 1, 2022, 00:00

  • PCR242 Understanding the Real-World Experience of People With Haemophilia A Receiving Turoctocog Alfa Pegol (N8-GP): Results From a Patient Experience Survey

    Dec 1, 2022, 00:00

  • EE408 Economic Evaluation of Endovascular Therapy for Acute Stroke With a Large Ischemic Region in China

    Dec 1, 2022, 00:00

  • MSR60 Literature Review of Statistical Methods Comparisons Through Simulations When Using External Control Arm for Regulatory or HTA Submissions

    Dec 1, 2022, 00:00

  • HTA60 Icosapent Ethyl in Addition to Statins Is a Cost-Effective Treatment in Patients at High Cardiovascular Risk With Elevated Triglycerides and Established Cardiovascular Disease or Diabetes With Risk Factor in the Netherlands

    Dec 1, 2022, 00:00

  • HPR144 TNF-Alfa Inhibitor Biosimilars: Qualitative Analysis of Uptake Determinants in Southern European Hospital Markets

    Dec 1, 2022, 00:00

  • EE674 Economic Burden of Patients With Glioblastoma in Five Key European Countries: A Systematic Review

    Dec 1, 2022, 00:00

  • HSD50 Evaluating the Pediatric Prescribing Pattern in a Health Facility in Nigeria

    Dec 1, 2022, 00:00

  • RWD137 Changing Priorities Among Physician Reported Reasons for Choice of Pharmacological gMG Treatments Across 5 European Countries

    Dec 1, 2022, 00:00

  • OP14 Racial and Ethnic Minority Inclusion in Clinical Outcome Assessment (COA) Research: A Reflection on Current Practices

    Dec 1, 2022, 00:00

  • EE630 A Cost-Effectiveness Analysis (CEA) of Adjuvant Nivolumab for Patients With Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC) in France

    Dec 1, 2022, 00:00

  • EE138 Healthcare Resource Use (HCRU) and Associated Costs Among Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CAR-T Cells in France – A Real-World Study Using Data From PMSI

    Dec 1, 2022, 00:00

  • MT38 Economic Value of Antibiotic-Impregnated External Ventricular Drain Catheters in Cerebrospinal Fluid Diversion Procedures

    Dec 1, 2022, 00:00

  • EE623 Cost-Minimization Analysis of a High Concentration Adalimumab Biosimilar: The Greek Context

    Dec 1, 2022, 00:00

  • EE280 Economic Burden of Hyperkalemia in Turkey

    Dec 1, 2022, 00:00

  • EPH46 Three-Year Epidemiology, Economic Burden and All-Cause Mortality Among Palmoplantar Pustolosis Patients: A Canadian Incidence Study of Inpatient Care, Emergency Departments, and Hospital- or Community-Based Outpatient Clinics

    Dec 1, 2022, 00:00

  • RWD30 Cost of Asthma Hospitalizations in the Brazilian Public Health

    Dec 1, 2022, 00:00

  • MSR94 An Exploration of How Influential Digitisation Approaches Are in Their Impact on Survival Estimates for Health Technology Assessment (HTA)

    Dec 1, 2022, 00:00

  • EE622 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention Interventions in Children: A Model Comparison Study

    Dec 1, 2022, 00:00

  • A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 2—Data From Nonwearables [Editor's Choice]

    Dec 1, 2022, 00:00

  • PCR239 Physician and Patient Preferences for Oral Anticoagulation Therapy Decision-Making in Atrial Fibrillation: Results From a National Best-Worst Scaling Survey in Turkey (PREF-AF)

    Dec 1, 2022, 00:00

  • HTA142 Potential Impact of Biomarker Guided-Decisions on Overtreatment in Immunotherapy for Non-Small Cell Lung Cancer Patients

    Dec 1, 2022, 00:00

  • HPR214 Challenges of Measuring Healthcare System Resilience

    Dec 1, 2022, 00:00

  • HTA137 Evidence Review Group Criticism of Clinical Effectiveness Systematic Reviews in NICE Oncology Submissions

    Dec 1, 2022, 00:00

  • SA46 Using Cloud Computing to Improve the Run-Time of Individual Patient Simulation Models

    Dec 1, 2022, 00:00

  • EE13 Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Portugal

    Dec 1, 2022, 00:00

  • SA14 Clinical Evidence on Corticosteroid Treatment Reported in the First Year of the COVID-19 Pandemic – Comparison of Clinical Trial Publications and Treatment Recommendation

    Dec 1, 2022, 00:00

  • OP3 Experience in Assessing Students’ Knowledge on TBL Methodology

    Dec 1, 2022, 00:00

  • PCR172 A Natural Language Processing (NLP) Approach to Automate Patients’ Testimonials Analysis

    Dec 1, 2022, 00:00

  • HSD25 Occupational Burnout Among Pediatric Neurologists Is Associated with Therapeutic Inertia in the Management of Spinal Muscular Atrophy

    Dec 1, 2022, 00:00

  • HPR84 The Impact of Medical Incidents on Follow-up Medical Treatment Under Different Medical Insurance Systems

    Dec 1, 2022, 00:00

  • RWD156 Long- and Short-Acting Methylphenidate Consumption in South Africa

    Dec 1, 2022, 00:00

  • EE428 Cost-Effectiveness of Collagen Laminin-Based Dermal Matrix Combined With Resveratrol Microparticles in Treatment of Diabetic Foot Ulcer Treatment in Turkey

    Dec 1, 2022, 00:00

  • CO163 The Increasing Use of Population-Adjusted Indirect Comparisons in the NICE Health Technology Assessment (HTA) Submission Process and the Response to These Methods

    Dec 1, 2022, 00:00

  • EE372 Inside CKD – A Projection of Clinical and Economic Burden of Chronic Kidney Disease in Turkey

    Dec 1, 2022, 00:00

  • EE626 Analysis of Healthcare Resource Use of the Robotic Surgery System for Lung Cancer in Japan

    Dec 1, 2022, 00:00

  • EPH158 Examination of the Glenohumeral Joint and Rotator Cuff Condition Among Youth Kayak-Canoe Athletes

    Dec 1, 2022, 00:00

  • HTA87 Evaluating the Framework and Evolution of the Italian Ministry of Health HTA Reports

    Dec 1, 2022, 00:00

  • CO131 Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Patients in Finland (FINPAH) – A Descriptive Retrospective Real World Cohort Study Between 2008 and 2020

    Dec 1, 2022, 00:00

  • EE475 Observational, Retrospective Study on the Evaluation of Direct and Indirect Costs Generated by Multiple Myeloma (MM) in Algeria

    Dec 1, 2022, 00:00

  • EE164 Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea: An Exploratory Analysis

    Dec 1, 2022, 00:00

  • PCR279 Value-Based Assessment of Clinical Trial Outcomes: A Hypothetical Example Using the Childhood Autism Rating Scale in Autism Spectrum Disorder

    Dec 1, 2022, 00:00

  • CO103 Prognostic Models for Short-Term Annual Risk of Severe Acute Complications and Mortality in Patients Living With Type 2 Diabetes Using a National Medical Claim Database

    Dec 1, 2022, 00:00

  • RWD43 Early Symptom-Change Contributes to the Outcome Prediction of Cognitive Behavioral Therapy for Depression Patients: A Machine Learning Approach

    Dec 1, 2022, 00:00

  • CO37 Reduction of Length of Hospital Stay in Patients Undergoing Major Planned Orthopedic Surgery After the Implementation of the Patient Blood Management (PBM) in Italy

    Dec 1, 2022, 00:00

  • EPH123 Estimating ADHD Prevalence and ADHD-Associated Health Care Costs Based on Claims Data

    Dec 1, 2022, 00:00

  • CO4 How Can the Long-Term Benefits and Harms of Screening Be Transparently Quantified and Contrasted for Informed Decision-Making? Colorectal Cancer Screening for Persons at Familial Risk (FARKOR)

    Dec 1, 2022, 00:00

  • P2 The Value of Vaccination: Capturing the Impact of Vaccination on Health Equity in Health Economic Analysis

    Dec 1, 2022, 00:00

  • EPH163 Burden of Diffuse Large B-Cell Lymphoma (DLBCL) in Germany – A Retrospective Statutory Health Insurance Claims Data Analysis

    Dec 1, 2022, 00:00

  • EE436 General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations

    Dec 1, 2022, 00:00

  • CO30 Therapeutic Role of Melatonin in Pediatric Migraine: A Systematic Review and Meta-Analysis

    Dec 1, 2022, 00:00

  • PCR191 Classification of Functioning, Disability Health: Validity of Preference-Weighted Scores

    Dec 1, 2022, 00:00

  • EE218 Cost-Utility Analysis Comparing Robot-Assisted Radical Prostatectomy Versus Robotic Stereotactic Body Radiotherapy With Artificial Intelligence for the Treatment of Prostate Cancer

    Dec 1, 2022, 00:00

  • HTA10 Carer Health-Related Quality of Life in National Institute for Health and Care Excellence (NICE) Appraisals: An Update of the Pennington Review

    Dec 1, 2022, 00:00

  • PCR13 Economic Advantages Associated With MS DMTs Mode of Administration

    Dec 1, 2022, 00:00

  • MSR141 Building Bridges: What Pandemic Preparedness Can Learn From Real-Option Value Analyses of Water Infrastructure in the Netherlands

    Dec 1, 2022, 00:00

  • MSR99 Cartography of Biostatistics and Machine Learning Methods to Identify Prognostic Factors

    Dec 1, 2022, 00:00

  • RWD150 Characteristics of Plaque Psoriasis Patients Initiating Guselkumab by Country: A Multi-National, Real-World Survey of Dermatology Practices

    Dec 1, 2022, 00:00

  • PCR288 Understanding Unmet Needs Relating to Unintentional Non-Adherence in Patients With Heart Disease – Review of Existing Evidence to Inform Patient-Centered Interventions

    Dec 1, 2022, 00:00

  • HSD46 Human Resources Costs in Breast Cancer Biopsy Processing in Chile: What's the Impact of Human Resources?

    Dec 1, 2022, 00:00

  • Meeting

    Dec 1, 2022, 00:00

  • PCR263 What Does the EQ-5D-Y-5L Measure in Comparison to Other Generic Paediatric Health Related Quality of Life Instruments?

    Dec 1, 2022, 00:00

  • CO38 Transdiagnostic Analysis of Mental Disorder Symptoms Associated With Increased Frequency of Psychiatric Hospitalisation

    Dec 1, 2022, 00:00

  • HPR210 Future BeNeLuxA Success – A Partnership vs a Prescription Model

    Dec 1, 2022, 00:00

  • MT39 Factors Influencing the Uptake of Magnetic Resonance Imaging-Guided High Intensity Focused Ultrasound for Painful Bone Metastases in Europe: A Group Concept Mapping Study

    Dec 1, 2022, 00:00

  • HTA266 Hierarchical Network Meta-Analysis Models for the Inclusion of Randomised and Observational Comparative Studies in Evidence Synthesis

    Dec 1, 2022, 00:00

  • HPR93 Turkiye-Based Health Economics and Outcome Studies Published in ISPOR

    Dec 1, 2022, 00:00

  • PCR97 Patient and Caregiver Insight Into the Impact of Non-Muscle Invasive Bladder Cancer and Its Treatments: A Social Media Review

    Dec 1, 2022, 00:00

  • RWD91 The Burden of Fall by Cause and Injury Type in Older Populations and Its Impact on Healthcare Utilization in the US

    Dec 1, 2022, 00:00

  • CO151 Estimating the Benefit of Esketamine Nasal Spray Versus Real-World Treatment on Patient-Reported Functional Remission: Results From the Iceberg Study

    Dec 1, 2022, 00:00

  • EPH175 Identification and Quantification of Atopic Dermatitis Patients With Insufficient Disease Control Under Conventional Systemic Treatments in Germany: A Feasibility Study

    Dec 1, 2022, 00:00

  • PCR246 Patient Preferences Regarding Thrombopoietin-Receptor Agonists for Immune Thrombocytopenia in Italy (TRAPeze Italy Study)

    Dec 1, 2022, 00:00

  • EE667 The Opportunity of High-Dose Vaccination Against Influenza for Adults Aged 60 and Above in the Netherlands

    Dec 1, 2022, 00:00

  • HPR40 Cost-Effectiveness and Budget Impact of Baloxavir Marboxil in the Netherlands Based on Post-COVID Influenza Season Scenarios

    Dec 1, 2022, 00:00

  • CO8 Ponatinib vs Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: A Matching Adjusted Indirect Comparison

    Dec 1, 2022, 00:00

  • SA70 Survey of Sport-Specific Lower Limb Injuries in 15 of Hungary's Most Popular Sports

    Dec 1, 2022, 00:00

  • SA28 Unique Device Identifiers for Cardiac Implantable Electronic Devices – A Data Quality Assessment of Administrative Hospital Data in Portugal

    Dec 1, 2022, 00:00

  • CO93 Rates of Disease-Related Hospitalization and Colectomy in Real-World Patients With Ulcerative Colitis on Anti-Tnf Agents: Evidence From a Systematic Review

    Dec 1, 2022, 00:00

  • EE633 A Targeted Literature Review of the Modelling Approaches and Challenges in Early-Stage Oncology Treatment Sequence Models

    Dec 1, 2022, 00:00

  • RWD19 Real-World Disease Burden of Chronic Obstructive Pulmonary Disease: A Retrospective Population-Based Cohort Study in Tianjin, China

    Dec 1, 2022, 00:00

  • HTA270 Use of Patient Preference Studies to Support HTA Submissions in Oncology

    Dec 1, 2022, 00:00

  • EPH160 Burden of Illness (BOI) and Paucity of Treatment of the Mosquito-Borne Chikungunya Virus (CHIKV)

    Dec 1, 2022, 00:00

  • P54 Antimicrobial Resistance Associated With Worse Outcomes in Hospitalized Adults With Pneumococcal Disease

    Dec 1, 2022, 00:00

  • PCR131 Resilience, and Positive Parenting in Parents of Children With Autism and Intellectual Disability: Evidence From the Impacts of the COVID-19 Pandemic on Family's Quality of Life and Parent-Child Relationships

    Dec 1, 2022, 00:00

  • PCR170 Mapping IWQOL-Lite Onto EQ-5D-5L and SF-6DV2 in Chinese Overweight and Obese Population

    Dec 1, 2022, 00:00

  • EE283 Health Economic Impact of Medication Non-Adherence to Direct Oral Anticoagulants in Austria

    Dec 1, 2022, 00:00

  • CO143 Project Ideate: Creating a Novel Linked Real World Data Environment in Wales for Use in an Experimental, Retrospective Outcome-Based Agreement of a Breast Cancer Treatment

    Dec 1, 2022, 00:00

  • HTA22 ITC Appraisal by French HTA Committees: Comprehensive Review and Comparison

    Dec 1, 2022, 00:00

  • EE505 Systematic Literature Review of Economic Evaluations for 1L Treatment of Advanced/Metastatic NSCLC in the EU5

    Dec 1, 2022, 00:00

  • PCR168 The Changing Face of Qualitative Interviewing in Clinical Outcome Assessments Research: Conducting Qualitative Interviews Post COVID-19

    Dec 1, 2022, 00:00

  • EE359 Real-World Utilization, Treatment Frequency, and Bleeding Outcomes on Damoctocog Alfa Pegol in Haemophilia A Care: Insights From a German Cohort Within the CHESS II Study

    Dec 1, 2022, 00:00

  • EPH138 Understanding the Prevalence and Burden of Diabetic Ketoacidosis (DKA) in People With T1DM at High Risk for DKA: A Structured Literature Review

    Dec 1, 2022, 00:00

  • PCR110 International X-Linked Hypophosphataemia (XLH) Registry: Capturing Patient-Reported Outcome Data

    Dec 1, 2022, 00:00

  • HSD94 A Novel Method to Measure Health

    Dec 1, 2022, 00:00

  • EE29 Burden of Disease and Cost of Illness of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Bulgaria

    Dec 1, 2022, 00:00

  • EPH186 Public Health Impact of Immunotherapies in Advanced Cancers in Fran A National Retrospective Estimate Until End of 2020

    Dec 1, 2022, 00:00

  • HTA251 Determining Factors of Simplified Evaluations in Norwegian Health Technology Assessments

    Dec 1, 2022, 00:00

  • RWD164 The Impact of the COVID-19 Pandemic on Patients With Type 2 Diabetes in Gree Results From a Real-World Study

    Dec 1, 2022, 00:00

  • RWD157 Challenges and Opportunities of Using Electronic Health Records in Multi-Country Studies

    Dec 1, 2022, 00:00

  • HTA252 Analyzing Critical Drivers for Success in the Implementation of Outcome-Based Agreements to Manage Clinical Uncertainty Risks in Spain

    Dec 1, 2022, 00:00

  • EE194 Modelling Long-Term Clinical Outcomes of Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in the United States

    Dec 1, 2022, 00:00

  • HSD43 COPD Patients Receiving Fixed or Open-Label Triple Therapy: Initiation and Persistence of Treatment Based on Data From a Real-World Ambulatory Medicalized Database in France

    Dec 1, 2022, 00:00

  • HTA151 The NICE Cost Comparison Pathway - How Much Evidence Is Required to Meet the Criteria?

    Dec 1, 2022, 00:00

  • EPH49 Nosocomial Infections With Methicillin-Resistant Staphylococcus Aureus (SARM) Potentially Avoided With the Use of Dalbavancin During Hospital Treatment of Acute Bacterial Skin and Skin Structure Infections in Spain

    Dec 1, 2022, 00:00

  • HPR114 Is No Therapy a Therapy? Effects of Watchful Waiting as Appropriate Comparator Therapy for New Drugs on Benefit Assessment and Pricing in Germany

    Dec 1, 2022, 00:00

  • Exploring the Impact of Cancer Treatment on Patients' Quality of Life

    Dec 1, 2022, 00:00

  • MT44 Extent of Use of Artificial Intelligence and Machine Learning Protocols in Cancer Diagnosis: A Scoping Review

    Dec 1, 2022, 00:00

  • HTA131 An Early Health Technology Assessment of Non-Invasive Fractional Flow Reserve Versus Standard Diagnostics in Patients With Stable Chest Pain in the Netherlands

    Dec 1, 2022, 00:00

  • EE617 Cost-Effectiveness of Meningococcal B Vaccination in the Netherlands

    Dec 1, 2022, 00:00

  • MSR46 A Bayesian Hierarchical Modelling Approach for Indirect Comparison of Response Outcomes in Histology-Independent Therapies

    Dec 1, 2022, 00:00

  • EE67 Cost Per Responder and Number Needed to Treat of iGlarlixi vs Premix BIAsp 30 in Algerian Setting

    Dec 1, 2022, 00:00

  • PCR276 Difficulties of Elimination Diets - Experiences of Allergy / Intolerance Among Young Adults

    Dec 1, 2022, 00:00

  • RWD168 ER Visits, Procedures Conducted, and Associated Cost

    Dec 1, 2022, 00:00

  • EPH107 Treatment Landscape for Patients With Advanced Systemic Mastocytosis in Germany in 2015 to 2020 Based on Claims Data Analysis

    Dec 1, 2022, 00:00

  • Paying for Kidneys: Reflections on Welfare Economics, Political Economy, and Market Design

    Dec 1, 2022, 00:00

  • P39 Does the Choice of Modelling Approach Matter When Modelling Stroke Prevention Therapy?

    Dec 1, 2022, 00:00

  • SA34 Identifying References in a Literature Review Update: A Study Exploring Three Alternative Approaches

    Dec 1, 2022, 00:00

  • EE649 Contrasting 4 Different Mortality Predictions in Patients With Type 1 Diabetes Using the IQVIA Core Diabetes Model

    Dec 1, 2022, 00:00

  • HPR197 Designing a Performance-Based Risk Sharing Arrangement for Aducanumab

    Dec 1, 2022, 00:00

  • PCR217 The Impact of Poor Medication Adherence on Clinical Outcomes and Health Resource Use in Hypertension and/or Dyslipidaemia: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • EE314 Economic Impact of Feno Testing on the Italian Population With Asthma

    Dec 1, 2022, 00:00

  • MSR89 Evaluating Prediction Model Calibration at the Moderate-Strong Level Using Patient Subgroups Identified With Clustering Analysis

    Dec 1, 2022, 00:00

  • MSR14 Developing an Abbreviated WHOQOL-BREF for Patients With Major Chronic Diseases Using the IRT Model

    Dec 1, 2022, 00:00

  • EE47 Micro-Costing of Hematopoietic Cell Transplantation, Graft-Versus-Host Disease and Veno-Occlusive Disease Associated with the Treatment of Acute Myeloid Leukemia in Argentina

    Dec 1, 2022, 00:00

  • EPH16 Antidiabetic Drugs and the Incidence of Parkinson's Disease in Patients With Type 2 Diabetes: A Case-Control Study

    Dec 1, 2022, 00:00

  • RWD12 Medication Adherence and Quality of Life of Patients With Multiple Sclerosis in Bulgaria - A Pilot Study

    Dec 1, 2022, 00:00

  • EPH8 Factors Associated With Oral Anticoagulant Switching in Patients With Atrial Fibrillation

    Dec 1, 2022, 00:00

  • EE612 Healthcare Resource Utilization and Costs Among Patients With Chronic Obstructive Pulmonary Disease in the United States

    Dec 1, 2022, 00:00

  • HTA197 What Drives the Limited Scope of French National Authority for Health (HAS) Economic Opinions for Rare Diseases in France?

    Dec 1, 2022, 00:00

  • CO149 Epidemiology and Burden of Oral Complications Following Breast Cancer Treatment - A Systematic Literature Review (PROSPERO CRD42021272130) - Mucositis and Stomatitis Incidence From Randomized Trials

    Dec 1, 2022, 00:00

  • HTA140 Current Changes in Europe Impacting Orphan Drugs Access: A Focus on the Latest Reforms in the EU4 and England

    Dec 1, 2022, 00:00

  • HSD79 Physicians’ Experience and Perceptions of Tetrabenazine for the Treatment of Tardive Dyskinesia

    Dec 1, 2022, 00:00

  • HTA176 A Systematic Literature Review of Rationale, Methods, and Use of Cost-Effectiveness Thresholds in Health Technology Assessments

    Dec 1, 2022, 00:00

  • PCR126 Patient-Reported Experience With Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea – Results From a Pilot Study in Germany

    Dec 1, 2022, 00:00

  • EE18 Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders

    Dec 1, 2022, 00:00

  • PCR272 Attitudes Towards Coronavirus Vaccination Among the Hungarian Population

    Dec 1, 2022, 00:00

  • PCR113 Are Patient and General Population Samples Fundamentally Different? An Exploration Using a Discrete Choice Experiment (DCE)

    Dec 1, 2022, 00:00

  • EE512 Comparing Costs of Immune Checkpoint Inhibitors for Treatment of 1L NSCLC in Colombia – A Cost Minimisation Analysis

    Dec 1, 2022, 00:00

  • CO11 Comparison of Relapse Rates in Ulcerative Colitis Patients With Mayo Endoscopic Score of 0 or 1: Systematic Literature Review and Meta-Analysis

    Dec 1, 2022, 00:00

  • HTA62 One Size Fit All? The Impact of EUnetHTA Joint Clinical Assessments on National Reimbursement

    Dec 1, 2022, 00:00

  • HPR2 Criteria to Define Rare Diseases and Orphan Drugs Systematic Literature Review

    Dec 1, 2022, 00:00

  • EPH19 Long Term Epidemiological Impact of Adjuvant Atezolizumab in Preventing the Recurrence of Early PDL1 High Non-Small Cell Lung Cancer in Europe

    Dec 1, 2022, 00:00

  • EE200 A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs (NNIADS): Trends in Decision-Analytical Models (DAM) for Modelling of Type 2 Diabetes Mellitus (T2DM)

    Dec 1, 2022, 00:00

  • RWD58 Coding of Multiple Sclerosis Subtypes in German Administrative Claims Data: A Validation Study Using the MSDS-AOK PLUS Linked Database

    Dec 1, 2022, 00:00

  • HTA173 Productivity Losses in Pharmacoeconomic Guidelines in Europe and Asia: A Qualitative Review of Guidelines

    Dec 1, 2022, 00:00

  • HTA11 U.S. Commercial Payer and Rare Disease Patient Stakeholder Perceptions of Value of Orphan Drugs

    Dec 1, 2022, 00:00

  • MSR58 How Do Mapping Studies Take into Account the Methodological Challenges of Repeated Measurements From the Same Individuals Over Time?

    Dec 1, 2022, 00:00

  • EPH77 Prevalence of Common Chronic Diseases Among Overweight and Obese Adults in Greece

    Dec 1, 2022, 00:00

  • PCR221 Health-Related Quality of Life Among Working Nurses in Hong Kong: The Role of Resilience Under the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • MT30 A Systematic Review of Clinical and Economic Literature of Breast Cancer Screening with Digital Breast Tomosynthesis (DBT) Combined With Synthesised Two-Dimensional Mammography (S2D) Versus Digital Mammography Alone (DM)

    Dec 1, 2022, 00:00

  • EE438 Assessing the Cost-Effectiveness of Axicabtagene Ciloleucel Compared With Other CAR T-Cell Therapies in the Treatment of Diffuse Large B-Cell Lymphoma in the UK

    Dec 1, 2022, 00:00

  • RWD36 Comparison of True Versus Apparent Survival in Patients With Metastatic Non-Small Cell Cancer Treated in the Real-World Setting

    Dec 1, 2022, 00:00

  • PCR260 Cross-Sectional Quantitative Evaluation of a Novel Patient-Reported Outcome Measure in Familial Chylomicronemia Syndrome

    Dec 1, 2022, 00:00

  • EE352 New Reimbursement Policy on Costly Treatments for Rehabilitation Care in Fran Estimated Impact in a University Hospital

    Dec 1, 2022, 00:00

  • HSD45 Breast Cancer Biopsy Rates in Chile: Is There Justification for Adopting Innovative Anatomic Pathology Technologies in Public Providers?

    Dec 1, 2022, 00:00

  • MSR87 Understanding Feline Pruritis From the Pet Owners Perspective: Can Social Media Listening Identify and Describe a Pet Patients Pathway Through a Disease Process in Veterinary Medicine?

    Dec 1, 2022, 00:00

  • EE190 Association of Total Annual Costs of Duchenne Muscular Dystrophy With Disease Severity

    Dec 1, 2022, 00:00

  • HSD54 Value-Based Healthcare (VBH): Application of Time-Driven-Activity-Based Costing (TDABC) Methodology in an Ophthalmic Clinic for Patients With Macular Degeneration (MD)

    Dec 1, 2022, 00:00

  • PCR215 Quality of Life Study of Adult Population With Inflammatory Bowel Disease

    Dec 1, 2022, 00:00

  • RWD34 Comparison of ICU/Ventilator Usage Among Vaccinated and Unvaccinated COVID-19 Patients

    Dec 1, 2022, 00:00

  • EE227 Healthcare Resource Utilization and Costs Among Patients with Moderately-to-Severely Active Crohn’s Disease Treated with Ustekinumab: Real-World Evidence

    Dec 1, 2022, 00:00

  • HSD111 Evaluation of the Implementation of Value-Based Healthcare With a Weekly Digital Follow-up of Lung Cancer Patients in Clinical Practice

    Dec 1, 2022, 00:00

  • SA82 A Bayesian Network Meta-Analysis of the Tyrosine Kinase Inhibitors (TKI) for ALK-Positive Advanced Non-Small Cell Lung Cancer With or Without Brain Metastasis

    Dec 1, 2022, 00:00

  • HPR176 Reimbursement of Antineoplastic and Immunomodulating Agents in Turkey: Comparison With Approvals of the FDA Between 2010-2021

    Dec 1, 2022, 00:00

  • RWD73 Epidemiology and Burden of Sickle Cell Disease in Fran Real-Life Analysis Using Data From the Echantillon Generaliste Des Bénéficiaires (EGB)

    Dec 1, 2022, 00:00

  • EE238 Protocol for an EQ-5D-5L Elicitation Study Regarding Health State Valuations for Surviving Patients at Intensive Care Units

    Dec 1, 2022, 00:00

  • SA44 Meta-Analysis of Time-to-Event Oncology Outcomes for Health Economic Modelling

    Dec 1, 2022, 00:00

  • MSR122 Examining the Relationships and the Effects of Gender and Grade on Seven Widely Used Well-Being Scales

    Dec 1, 2022, 00:00

  • EE64 Healthcare Resource Utilisation and Medical Costs Among Patients With High-Grade Serous Ovarian Cancer in a Real-Life Setting in Finland: The OCRWE-Finland Study

    Dec 1, 2022, 00:00

  • PCR274 One Universal Translation to Rule Them All...or Not?

    Dec 1, 2022, 00:00

  • HPR13 Impact of Income Shock on Health Care Utilization of Rural Residents in China - Evidence From CHARLS

    Dec 1, 2022, 00:00

  • HSD52 Demonstration of the Kitagawa Decomposition to Understand Racial/Ethnic Disparities by Partitioning Within- and Between-Hospital Mean Effects

    Dec 1, 2022, 00:00

  • CO20 Predicted Time to Wheelchair and Ventilation Events Comparing Avalglucosidase Alfa (AVA) Versus (vs) Alglucosidase Alfa (ALG) Using a Model of Late-Onset Pompe Disease (LOPD)

    Dec 1, 2022, 00:00

  • EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus

    Dec 1, 2022, 00:00

  • EE45 Budget Impact Analysis of Introducing Amino Acid Formula to Infants With Cow's Milk Protein Allergy in Egypt

    Dec 1, 2022, 00:00

  • SA40 Outcomes for Patients with Microsatellite Instability-High Metastatic Colorectal Cancer in the Real World Treated with Standard of Care Versus Patients Treated with Nivolumab Plus Low-Dose Ipilimumab in CheckMate 142

    Dec 1, 2022, 00:00

  • P38 One Size Does Not Fit All: Calculating the Cost-Effectiveness of Multiple Indications of Pembrolizumab in the Netherlands

    Dec 1, 2022, 00:00

  • EE33 Impact on Hospital Healthcare Resources, Comparison of Endoluminal Versus Surgical Treatment Strategies for Lower Limb Bypass in PAD Patients

    Dec 1, 2022, 00:00

  • HTA93 The Impact of the EU-JCA Throughout European Healthcare Systems

    Dec 1, 2022, 00:00

  • HTA212 Real-Time Delphi Consultation on Medication Adherence Technologies: Consistency of Views Among Different Stakeholder Groups

    Dec 1, 2022, 00:00

  • CO148 Time in Remission as an Alternative Outcome Measure for Ankylosing Spondylitis: A 4-Year Prospective Study of 1900 Users of Anti-TNF

    Dec 1, 2022, 00:00

  • HTA13 How Health Technology Assessment Agencies View Clinical Evidence for Tumor Agnostic Therapies

    Dec 1, 2022, 00:00

  • OP4 Training Needs Assessment to Improve Regulatory Compliance and Professional Competency in the Pharmaceutical Industry

    Dec 1, 2022, 00:00

  • MSR135 Alternative Methods for Sampling Ordered Parameters in Probabilistic Sensitivity Analysis (PSA)

    Dec 1, 2022, 00:00

  • RWD80 The Disease Burden of Invasive Candidiasis in Germany: A Non-Interventional, Retrospective Cohort Analysis of Real-World Data

    Dec 1, 2022, 00:00

  • EE81 The Budget Impact of Cangrelor for the Treatment of Patients Undergoing Percutaneous Coronary Intervention When Oral P2Y12 Inhibitors Are Not Feasible or Desirable in the UK

    Dec 1, 2022, 00:00

  • CO92 Systematic Review of Currently Available Therapies for Crohn's Disease and Ulcerative Colitis

    Dec 1, 2022, 00:00

  • EE101 Comparison of Two French Cost-Effectiveness Opinions for the Same First-Line Treatment Combination in Renal Cell Carcinoma

    Dec 1, 2022, 00:00

  • EE513 Health Economic Evaluation Incorporating Mixture Cure Survival Analysis of Nivolumab Plus Ipilimumab for Previously Untreated Metastatic NSCLC

    Dec 1, 2022, 00:00

  • MT27 Budget Impact of a Novel Digital Therapeutic for Amblyopia From a US Private Insurer Perspective

    Dec 1, 2022, 00:00

  • EE595 Did We Follow the Right Approach in Economic Evaluations by Discounting Health Gain?

    Dec 1, 2022, 00:00

  • EE215 Pharmacoeconomic Analysis of Adjuvant Nivolumab for Patients With Resected Esophageal or Gastroesophageal Junction Cancer in Switzerland

    Dec 1, 2022, 00:00

  • HSD81 European Delphi Panel to Build Consensus on Tapering and Discontinuation of Thromboprotein-Receptor Agonists in Patients With Immune Thrombocytopenia

    Dec 1, 2022, 00:00

  • EE355 Budget Impact Model of a New rFVIIa (Eptacog Beta), for the On-Demand Treatment of Spontaneous Bleeding Events and Surgical Bleedings Among Hemophilia Patients with Inhibitors: A Payer Perspective From UK

    Dec 1, 2022, 00:00

  • EPH199 Epidemiology of Eye Disorders Due to the Use of Video Display Terminals in France, Germany, Italy, Spain and United Kingdom – A Systematic Literature Review

    Dec 1, 2022, 00:00

  • PCR119 Who We Are Matters: Inclusive Demographic Data Collection in Patient-Centered Outcomes Research

    Dec 1, 2022, 00:00

  • PCR150 Physicians’ Perceptions of the Impact of COVID-19 on Patient Access and Adherence

    Dec 1, 2022, 00:00

  • HPR171 COVID 19 Vaccination - How to Support Decisions on Vaccination Prioritization for New Variants of Concern?

    Dec 1, 2022, 00:00

  • EE567 Environmental Impact and Sustainability of Surgical Sets: The 4S Approach

    Dec 1, 2022, 00:00

  • EPH144 The Impact of COVID-19 Pandemic on the Detection and Management of Cancer: A German Claims Data Analysis

    Dec 1, 2022, 00:00

  • HSD9 Comparing the Quality of the Irish Healthcare System Versus the Healthcare Systems of the Nordic Countries Using Health Outcomes Data

    Dec 1, 2022, 00:00

  • EE173 Cost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in Francecost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in France

    Dec 1, 2022, 00:00

  • HTA187 Best Practices for the Development of Budget Impact Models at Regional Level

    Dec 1, 2022, 00:00

  • EE341 Economic Evaluations of Technologies for the Treatment of Rare Diseases in Latin America and Southeast Asia: A Scoping Review

    Dec 1, 2022, 00:00

  • CO54 Dupilumab vs Placebo Improves Symptoms, Asthma Control, and Asthma-Related Quality of Life in Patients With Oral Corticosteroid-Dependent Severe Asthma Through 48 Weeks of Follow up

    Dec 1, 2022, 00:00

  • EPH121 Future Trends of the COVID-19 Pandemics: What Should We Expect?

    Dec 1, 2022, 00:00

  • MSR92 Challenges to Implementing Real-World Evidence (RWE)

    Dec 1, 2022, 00:00

  • PCR180 Real-World Impact of Patient-Reported Outcome Measurement on Overall Survival and Healthcare Resource Utilization in Cancer Patients

    Dec 1, 2022, 00:00

  • PCR259 Factors Influencing Crowdfunding Donations for Patients With Dementia

    Dec 1, 2022, 00:00

  • HPR198 Faster, Simpler, and Easier: Analyzing the Reform of the French Early Access Pathway

    Dec 1, 2022, 00:00

  • EPH103 Vitiligo in Italy Through Administrative Healthcare Data

    Dec 1, 2022, 00:00

  • RWD87 Association Between Functional Endpoints and Quality-of-Life Outcomes in Huntington's Disease Gene Carriers: Results From a Real-World Data Analysis of the Enroll-HD Global Registry

    Dec 1, 2022, 00:00
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27 (current)
  • 28
  • 29
  • 30
  • »